End-to-End Capability
From nucleic acid synthesis to GMP-ready therapeutic components.
Scalable Manufacturing
Research, pilot, and commercial-scale production under unified SOPs.
Quality Assurance
Dual verification for sequence integrity (Sanger + NGS where applicable) and comprehensive analytical testing.
Regulatory Compliance
Facilities and processes aligned with FDA, EMA, and NMPA standards for gene therapy manufacturing.
In-House Integration
Raw materials, instruments, and production capacity under complete supply chain control.